AMGN

Amgen Inc
238.49
5.39 (2.31%)
Stock Name Stock Symbol Market Stock Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
5.39 2.31% 238.49 11:00:00
Open Price Low Price High Price Close Price Previous Close
234.30 233.01 238.5028 238.03 233.10
more quote information »

Recent News

Date Time Source Heading
24/3/202320:45PRNUSAMGN SHAREHOLDER ALERT: Jakubowitz Law Reminds Amgen..
22/3/202320:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
21/3/202310:17EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:15EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:14EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:13EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:11EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:10EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:09EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:08EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202310:06EDGARStatement of Changes in Beneficial Ownership (4)
21/3/202309:43EDGARStatement of Changes in Beneficial Ownership (4)
10/3/202309:20PRNUSAMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE..
10/3/202308:25EDGARCurrent Report Filing (8-k)
08/3/202308:00PRNUSAMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND
04/3/202308:00PRNUSAMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE..
02/3/202301:00PRNUSAMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN..
23/2/202301:00PRNUSAMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION..
17/2/202322:02EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
17/2/202300:31EDGARCurrent Report Filing (8-k)
16/2/202322:03EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/2/202309:11EDGARAutomatic Shelf Registration Statement of Securities of..
10/2/202308:28EDGARAnnual Report (10-k)
10/2/202308:00PRNUSAMGEN TO PRESENT AT THE 2023 SVB SECURITIES GLOBAL BIOPHARMA..
10/2/202303:12EDGARAmended Statement of Ownership (sc 13g/a)
08/2/202306:13EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202301:00EDGARAmended Statement of Ownership (sc 13g/a)
03/2/202301:00PRNUSTEZSPIRE® APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH..
02/2/202305:30DJNAmgen Shares Slip 4.1% Following Decline in 4Q Profit,..
01/2/202315:34PRNUSAMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH..
01/2/202308:51DJNAmgen 4Q Profit Declines, Revenue Ticks Down Slightly
01/2/202308:16EDGARCurrent Report Filing (8-k)
01/2/202308:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL..
31/1/202322:00PRNUSAMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®,..
27/1/202308:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR..
07/1/202308:00PRNUSAMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE..
05/1/202308:00PRNUSAMGEN TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE..
23/12/202223:48DJNLegoChem Biosciences, Amgen in Licensing Agreement
23/12/202208:44EDGARCurrent Report Filing (8-k)
14/12/202208:00PRNUSBLINCYTO® (BLINATUMOMAB) ADDED TO CONSOLIDATION CHEMOTHERAPY..
13/12/202211:50PRNUSAMGEN ANNOUNCES 10% INCREASE IN 2023 FIRST QUARTER DIVIDEND
13/12/202203:07DJNTrending: Amgen to Buy Horizon Therapeutics in Blockbuster..
12/12/202223:33EDGARCurrent Report Filing (8-k)
12/12/202223:11DJNAmgen to Buy Horizon Therapeutics for $27.8 Billion
12/12/202222:26DJNHorizon Therapeutics Shares Rally as Amgen Deal Said Near
12/12/202222:05PRNUSAMGEN TO HOST WEBCAST INVESTOR CALL FOLLOWING ANNOUNCED..
12/12/202222:00PRNUSRule 2.7 Announcement: Amgen Inc to Acquire Horizon..
12/12/202218:50TRMNAmgen (NASDAQ:AMGN) to Buy Horizon for $26B in its..
12/12/202214:15TRMNMizuho Securities Sticks to Their Hold Rating for Amgen..
07/12/202215:25TRMNAmgen (AMGN) Receives a Hold from SVB Securities
Your Recent History
NASDAQ
AMGN
Amgen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230325 05:11:48